Unexplained Painful Physical Symptoms in Patients with Major Depressive Disorder: Prevalence, Pathophysiology and Management
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Patients with major depression often report pain. In this article, we review the current literature regarding the prevalence and consequences, as well as the pathophysiology, of unexplained painful physical symptoms (UPPS) in patients with major depressive disorder (MDD). UPPS are experienced by approximately two-thirds of depressed patients. The presence of UPPS makes a correct diagnosis of depression more difficult. Moreover, UPPS are a predictor of a poor response to treatment and a more chronic course of depression. Pain, in the course of depression, also has a negative impact on functioning and quality of life. Frequent comorbidity of depression and UPPS has inspired the formulation of an hypothesis regarding a shared neurobiological mechanism of both conditions. Evidence from neuroimaging studies has shown that frontal-limbic dysfunction in depression may explain abnormal pain processing, leading to the presence of UPPS. Increased levels of proinflamatory cytokines and substance P in patients with MDD may also clarify the pathophysiology of UPPS. Finally, dysfunction of the descending serotonergic and noradrenergic pathways that normally suppress ascending sensations has been proposed as a core mechanism of UPPS. Psychological factors such as catastrophizing also play a role in both depression and chronic pain. Therefore, pharmacological treatment and/or cognitive therapy are recommended in the treatment of depression with UPPS. Some data suggest that serotonin and noradrenaline reuptake inhibitors (SNRIs) are more effective than selective serotonin reuptake inhibitors (SSRIs) in the alleviation of depression and UPPS. However, the pooled analysis of eight randomised clinical trials showed similar efficacy of duloxetine (an SNRI) and paroxetine (an SSRI) in reducing UPPS in depression. Further integrative studies examining genetic factors (e.g. polymorphisms of genes for interleukins, serotonin transporter and receptors), molecular factors (e.g. cytokines, substance P) and neuroimaging findings (e.g. functional studies during painful stimulation) might provide further explanation of the pathophysiology of UPPS in MDD and therefore facilitate the development of more effective methods of treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
Breivik, H., Collett, B., Ventafridda, V., Cohen, R., & Gallacher, D. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2005.06.009 · Cited by 5,486
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980 · cited 9×
“While the SNRIs appear to be effective in the treatment of chronic pain, the evidence from studies with SSRIs is inconsistent [85].”
InfluentialInflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · cited 1×
“In the brain, cytokines induce deregulation of both monoamine synthesis and reuptake, leading to reduced monoamine availability [59, 60].”
BackgroundDepression and Pain Comorbidity: A Literature Review
Bair, M. J., Robinson, R. L., Katon, W., & Kroenke, K. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.20.2433 · Cited by 3,463
Human brain mechanisms of pain perception and regulation in health and disease
Apkarian, A. V., Bushnell, M. C., Treede, R., & Zubieta, J. (2005) · European Journal of Pain · doi:10.1016/j.ejpain.2004.11.001 · Cited by 3,126
Theoretical perspectives on the relation between catastrophizing and pain
Sullivan, M. J. L., Thorn, B., Haythornthwaite, J. A., Keefe, F., Martin, M., Bradley, L. A., & Lefebvre, J. C. (2001) · The Clinical Journal of Pain · doi:10.1097/00002508-200103000-00008 · Cited by 2,472 · cited 1×
“[78], catastrophizing is currently defined as: ‘‘an exaggerated negative mental set brought to bear during an actual or anticipated painful experience’’.”
BackgroundMayberg, H. S., Liotti, M., Brannan, S. K., McGinnis, S., Mahurin, R. K., Jerabek, P. A., Silva, J. A., Tekell, J. L., Martin, C. C., Lancaster, J. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.675 · Cited by 2,416 · cited 1×
“Decreased brain glucose metabolism in the prefrontal cortex of depressed patients was a consistent finding in early positron emission tomography studies [47, 48] and was confirmed in more recent reports [49].”
ResultCross-national epidemiology of major depression and bipolar disorder
Weissman, M. M. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540040037030 · Cited by 2,302
Cognitive and emotional control of pain and its disruption in chronic pain
Bushnell, M. C., Čeko, M., & Low, L. A. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3516 · Cited by 2,076
Lamm, C., Decety, J., & Singer, T. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.10.014 · Cited by 2,016 · cited 2×
“clinical presentation or response to treatment [34].”
BackgroundChronic back pain is associated with decreased prefrontal and thalamic gray matter density
Apkarian, A. V., Sosa, Y., Sonty, S., Levy, R. M., Harden, R. N., Parrish, T. B., & Gitelman, D. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2541-04.2004 · Cited by 1,434
Gold, P. W., & Chrousos, G. P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001032 · Cited by 1,274
Cuijpers, P., Berking, M., Andersson, G., Quigley, L., Kleiboer, A., & Dobson, K. S. (2013) · The Canadian Journal of Psychiatry · doi:10.1177/070674371305800702 · Cited by 1,066 · cited 1×
“Considerable evidence indicates that psychological methods, including cognitive-behavioural techniques, are useful in the treatment of both chronic pain [111–113] and depression [114].”
BackgroundKeeping pain out of mind: The role of the dorsolateral prefrontal cortex in pain modulation
Lorenz, J., Minoshima, S., & Casey, K. L. (2003) · Brain · doi:10.1093/brain/awg102 · Cited by 952 · cited 2×
“Moreover, it has been hypothesised that the DLPFC plays a role in ‘‘keeping pain out of mind’’ [38].”
BackgroundLiu, Y., Ho, R. C.-M., & Mak, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.003 · Cited by 948
A meta‐analytic study of changes in brain activation in depression
Fitzgerald, P. B., Laird, A. R., Maller, J., & Daskalakis, Z. J. (2008) · Human Brain Mapping · doi:10.1002/hbm.20426 · Cited by 903
Major depressive disorder: new clinical, neurobiological, and treatment perspectives
Kupfer, D. J., Frank, E., & Phillips, M. L. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60602-8 · Cited by 894 · cited 1×
“Disturbances of these structures and connecting pathways are responsible for the affective, motor and cognitive symptoms of depression [35].”
BackgroundMeta-analysis of psychological interventions for chronic low back pain
Hoffman, B. M., Papas, R. K., Chatkoff, D. K., & Kerns, R. D. (2007) · Health Psychology · doi:10.1037/0278-6133.26.1.1 · Cited by 844
Using Chronic Pain to Predict Depressive Morbidity in the General Population
Ohayon, M. M., & Schatzberg, A. F. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.39 · Cited by 617
Arnone, D., McIntosh, A. M., Ebmeier, K. P., Munafò, M. R., & Anderson, I. M. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.05.003 · Cited by 495 · cited 1×
“Accumulated evidence from neuroimaging studies has demonstrated slightly altered brain structures and functions in the frontal-limbic regions of patients with depression [39, 40] and in functional pain syndromes [41–46].”
BackgroundDahl, J., Ormstad, H., Aass, H. C. D., Malt, U. F., Bendz, L. T., Sandvik, L., Brundin, L., & Andreassen, O. A. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.019 · Cited by 424 · cited 1×
“antidepressants, a reduction in normal levels of cytokines was reported [67].”
BackgroundA Review of the Relationship between Proinflammatory Cytokines and Major Depressive Disorder
Young, J. J., Bruno, D., & Pomara, N. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.07.032 · Cited by 422
Impact of pain on depression treatment response in primary care
Bair, M. J., Robinson, R. L., Eckert, G. J., Stang, P. E., Croghan, T. W., & Kroenke, K. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000106883.94059.c5 · Cited by 371
The Association of Depression and Anxiety with Pain: A Study from NESDA
de Heer, E. W., Gerrits, M. M. J. G., Beekman, A. T. F., Dekker, J., van Marwijk, H. W. J., de Waal, M. W. M., Spinhoven, P., Penninx, B. W. J. H., & van der Feltz-Cornelis, C. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106907 · Cited by 363 · cited 2×
“[15] compared the impact of current and remitted depressive, anxiety and co-morbid disorders on different aspects of pain in a large sample of individuals with depressive and/or anxiety disorders vs.”
BackgroundRaskin, J., Wiltse, C. G., Siegal, A., Sheikh, J., Xu, J., Dinkel, J. J., Rotz, B. T., & Mohs, R. C. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.900 · Cited by 329
Abnormal endogenous pain modulation is a shared characteristic of many chronic pain conditions
Staud, R. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.41 · Cited by 290 · cited 1×
“The regulatory role of the DLPC in pain perception is related to modulation of cortico-subcortical and cortico-cortical pathways [53].”
BackgroundKeller, M., Montgomery, S., Ball, W., Morrison, M., Snavely, D., Liu, G., Hargreaves, R., Hietala, J., Lines, C., Beebe, K., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.013 · Cited by 286 · cited 1×
“’s study did not support the efficacy of aprepitant in MDD [74].”
ResultComorbid painful physical symptoms and depression: prevalence, work loss, and help seeking
Demyttenaere, K., Bonnewyn, A., Bruffaerts, R., Brugha, T., De Graaf, R., & Alonso, J. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.01.007 · Cited by 217 · cited 3×
“Moreover, an additive effect of depression and UPPS on work days lost has been demonstrated [6].”
BackgroundInfluentialThe role of depression and catastrophizing in musculoskeletal pain
Lintonl, S. J., Nicholasl, M. K., MacDonaldl, S., Boersmal, K., Bergboml, S., Maherl, C., & Refshaugel, K. (2011) · European Journal of Pain · doi:10.1016/j.ejpain.2010.08.009 · Cited by 198
Longitudinal association between pain, and depression and anxiety over four years
Gerrits, M. M. J. G., van Marwijk, H. W. J., van Oppen, P., van der Horst, H., & Penninx, B. W. J. H. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2014.10.011 · Cited by 172
The prevalence of pain in bipolar disorder: a systematic review and large-scale meta-analysis
Stubbs, B., Eggermont, L., Mitchell, A. J., De Hert, M., Correll, C. U., Soundy, A., Rosenbaum, S., & Vancampfort, D. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12325 · Cited by 129
Pain, not chronic disease, is associated with the recurrence of depressive and anxiety disorders
Gerrits, M. M., van Oppen, P., Leone, S. S., van Marwijk, H. W., van der Horst, H. E., & Penninx, B. W. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-187 · Cited by 106 · cited 2×
“cardiometabolic, respiratory, endocrine) were not found to be associated with the risk of recurrence [24].”
BackgroundLoggia, M. L., Berna, C., Kim, J., Cahalan, C. M., Martel, M.-O., Gollub, R. L., Wasan, A. D., Napadow, V., & Edwards, R. R. (2015) · The Journal of Pain · doi:10.1016/j.jpain.2015.04.003 · Cited by 74
Ratti, E., Bettica, P., Alexander, R., Archer, G., Carpenter, D., Evoniuk, G., Gomeni, R., Lawson, E., Lopez, M., Millns, H., et al. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113480990 · Cited by 69 · cited 1×
“Two of them confirmed that the blockade of central NK-R1 receptors with orvepitant [72] and aprepitant [73] is an efficacious mechanism for the treatment of MDD.”
BackgroundPerahia, D. G. S., Quail, D., Desaiah, D., Montejo, A. L., & Schatzberg, A. F. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.07.001 · Cited by 64 · cited 1×
“The results of this study revealed that a switch to duloxetine was associated with significant improvements in painful symptoms, time in pain and interference with functioning because of pain [108].”
ResultPresence and predictors of pain in depression: Results from the FINDER study
Demyttenaere, K., Reed, C., Quail, D., Bauer, M., Dantchev, N., Montejo, A. L., Monz, B., Perahia, D., Tylee, A., & Grassi, L. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.02.106 · Cited by 44 · cited 5×
“3 % of them met this criterion at baseline [8].”
BackgroundInfluential
Cited by
The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain
Sheng, J., Liu, S., Wang, Y., Cui, R., & Zhang, X. (2017) · Neural Plasticity · doi:10.1155/2017/9724371 · Cited by 775
Pain and Depression: A Systematic Review
IsHak, W. W., Wen, R. Y., Naghdechi, L., Vanle, B., Dang, J., Knosp, M., Dascal, J., Marcia, L., Gohar, Y., Eskander, L., et al. (2018) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000198 · Cited by 498
“Not surprisingly, pain comorbid withmajor depressive disorder (MDD) is frequent and can lead to impaired functioning, lower treatment response, and limited treatment options.(4,5) The two conditions often co-occur, exacerbate one another, and may display overlapping symptoms.”
BackgroundGenome-wide association study of medication-use and associated disease in the UK Biobank
Wu, Y., Byrne, E. M., Zheng, Z., Kemper, K. E., Yengo, L., Mallett, A. J., Yang, J., Visscher, P. M., & Wray, N. R. (2019) · Nature Communications · doi:10.1038/s41467-019-09572-5 · Cited by 243
De Diego-Adeliño, J., Crespo, J. M., Mora, F., Neyra, A., Iborra, P., Gutiérrez-Rojas, L., & Salonia, S. F. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2019705 · Cited by 67
IL-10 Is Associated with Increased Mu-Opioid Receptor Levels in Major Depressive Disorder
Al-Fadhel, S. Z., Al-Hakeim, H. K., Al-Dujaili, A. H., & Maes, M. (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2018.10.001 · Cited by 44
Metadata
- Authors
- Jaracz, J., Gattner, K., Jaracz, K., & Górna, K.
- Venue
- CNS Drugs
- Published
- 2016-04
- Volume
- 30
- Issue
- 4
- Pages
- 293-304
- ISSN
- 1172-7047 (ISSN-L)
- 1179-1934
- OpenAlex
- W2315582431
- Cited by
- 91
- References
- 37
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.